Updated Jul 16, 2026 · Last SEC filing 2026-07-15
Structure Therapeutics Inc. (GPCR) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-15. 2 Form 8-K material event filings were reported by GPCR in the last 90 days. 1 Form 144 notices of proposed sale were filed for GPCR stock. InsiderAlpha tracks every GPCR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001888886 |
|---|
| Form 4 filings (90d) | 9 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-15 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | J — Other acquisition / disposition [10b5-1] | 23.6K | $0.00 | — | SEC | |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | M — Option exercise [10b5-1] | 23.6K | $0.34 | $8K | SEC | |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | M — Option exercise | 23.6K | $0.34 | $8K | SEC | |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | J — Other acquisition / disposition | 23.6K | $0.00 | — | SEC | |
| Lang Matthew | COO & GC | A — Grant or award | 184.6K | $0.00 | — | SEC | |
| Yoon Jun | CHIEF FINANCIAL OFFICER | A — Grant or award | 104.1K | $0.00 | — | SEC | |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | A — Grant or award | 260.2K | $0.00 | — | SEC | |
| Coll Crespo Blas | CHIEF MEDICAL OFFICER | A — Grant or award | 75.9K | $0.00 | — | SEC | |
| Hall Ashley | Chief Development Officer | A — Grant or award | 47.7K | $0.00 | — | SEC | |
| Lin Xichen | CHIEF SCIENTIFIC OFFICER | A — Grant or award | 43.4K | $0.00 | — | SEC | |
| Ma Yingli | CHIEF TECHNOLOGY OFFICER | A — Grant or award | 32.5K | $0.00 | — | SEC | |
| Coll Crespo Blas | CHIEF MEDICAL OFFICER | F — Tax withholding / forfeiture | 11.8K | $20.99 | $248K | SEC | |
| Ma Yingli | CHIEF TECHNOLOGY OFFICER | F — Tax withholding / forfeiture | 11.3K | $20.99 | $237K | SEC | |
| Hall Ashley | Chief Development Officer | F — Tax withholding / forfeiture | 4.8K | $20.99 | $102K | SEC | |
| Stevens Raymond C | CHIEF EXECUTIVE OFFICER | F — Tax withholding / forfeiture | 53.5K | $20.99 | $1.12M | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Structure Therapeutics Inc. (GPCR). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Lin Xichen | 11 | $804K |
| Lang Matthew | 2 | — |
| DOBMEIER ERIC | 1 | — |
| WELCH DANIEL G | 1 | — |
| Waldstreicher Joanne | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in GPCR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live GPCR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.